Transforming respiratory diseases management: a CMO-based hospital pharmaceutical care model
The CMO model, tailored for respiratory patients, provides a comprehensive framework for improving pharmaceutical care. By focusing on patient-centered care, aligning therapeutic goals, and leveraging technology, this model addresses the multifaceted needs of individuals with respiratory conditions. Future studies are necessary to validate this model in other healthcare systems and ensure its broad applicability.
Authors
- Sara García-Gil (ORCID: https://orcid.org/0000-0002-8789-542X)
- Noé Garín (ORCID: https://orcid.org/0000-0002-1559-9453)
- Josefina Martínez‐Simón
- Borja Zarate-Tamames
- Sonia Jornet
- Ramón Morillo‐Verdugo (ORCID: https://orcid.org/0000-0002-8849-2737)
- M Calvín-Lamas (ORCID: https://orcid.org/0000-0003-3209-8252)
- Eva M. Garcia-Rebolledo
Institutions
- Universitat Autònoma de Barcelona (ES)
- Hospital Universitario de Canarias (ES)
- Hospital de Sant Pau (ES)
- Hospital Universitario Fundación Alcorcón (ES)
- Complexo Hospitalario Universitario A Coruña (ES)
- Hospital Universitario de Valme (ES)
- Hospital Universitario de Fuenlabrada (ES)
- Hospital Universitari Joan XXIII de Tarragona (ES)
- Instituto de Investigación Biomédica de A Coruña (ES)
- Universitat Ramon Llull (ES)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2024-10-23
- DOI
- https://doi.org/10.3389/fphar.2024.1461473
- Citations
- 7
- Primary Topic
- Inhalation and Respiratory Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 2.93